This article is more than 5 years old. Information may no longer be current.

FDA approves five ophthalmic ultrasound devices

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SALT LAKE CITY — The U.S. Food and Drug Administration has granted marketing approval to Paradigm Medical for the latest generation of its ophthalmic ultrasound devices, the company announced in a press release.

The newly approved devices include the P2000 A-Scan for measuring axial length, the P2200 Pachymeter for measuring corneal thickness and the P2500 A-Scan/Pachymeter, a combination device, according to the release. Also approved were the P37-II for detecting abnormalities within the eye and the P2700 AB/Scan, a portable version for use in both animals and humans, said Raymond Cannefax, CEO of Paradigm.

The products were developed in collaboration with the China-based ultrasound company Meda Co. Ltd., according to the release.